Impact of lack of suppression of glucagon on glucose tolerance in humans.
暂无分享,去创建一个
[1] C Meyer,et al. Effects of glucagon on renal and hepatic glutamine gluconeogenesis in normal postabsorptive humans. , 1998, Metabolism: clinical and experimental.
[2] L. Audoly,et al. Regulation of glucose production by NEFA and gluconeogenic precursors during chronic glucagon infusion. , 1998, American journal of physiology. Endocrinology and metabolism.
[3] M. Vranic,et al. Role of free fatty acids and glucagon in the peripheral effect of insulin on glucose production in humans. , 1998, The American journal of physiology.
[4] M. Camilleri,et al. Effects of glucagon on postprandial carbohydrate metabolism in nondiabetic humans. , 1998, Metabolism: clinical and experimental.
[5] R. Rizza,et al. Assessment of Hepatic Sensitivity to Glucagon in NIDDM: Use as a Tool to Estimate the Contribution of the Indirect Pathway to Nocturnal Glycogen Synthesis , 1997, Diabetes.
[6] C Cobelli,et al. Impaired Basal Glucose Effectiveness in NIDDM: Contribution of Defects in Glucose Disappearance and Production, Measured Using an Optimized Minimal Model Independent Protocol , 1997, Diabetes.
[7] V. Hruby,et al. Low level cyclic adenosine 3',5'-monophosphate accumulation analysis of [des-His1, des- Phe6, Glu9] glucagon-NH2 identifies glucagon antagonists from weak partial agonists/antagonists. , 1996, Endocrinology.
[8] J. Holst,et al. Glucagonostatic Actions and Reduction of Fasting Hyperglycemia by Exogenous Glucagon-Like Peptide I(7–36) amide in type I diabetic patients , 1996, Diabetes Care.
[9] C. Cobelli,et al. Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance. , 1996, The Journal of clinical investigation.
[10] J. Holst,et al. The Effect of Glucagon-Like Peptide I (GLP-I) on Glucose Elimination in Healthy Subjects Depends on the Pancreatic Glucoregulatory Hormones , 1996, Diabetes.
[11] R. B. Merrifield,et al. Antibodies against specific extracellular epitopes of the glucagon receptor block glucagon binding. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[12] J. Wahren,et al. A limitation in the use of mass isotopomer distributions to measure gluconeogenesis in fasting humans. , 1995, The American journal of physiology.
[13] D L Rothman,et al. Contribution of Hepatic Glycogenolysis to Glucose Production in Humans in Response to a Physiological Increase in Plasma Glucagon Concentration , 1995, Diabetes.
[14] R. Bergman,et al. Quantitation of measurement error with Optimal Segments: basis for adaptive time course smoothing. , 1993, The American journal of physiology.
[15] S. Mathewes,et al. Isolation of glucagon antagonists by random molecular mutagenesis and screening. , 1993, Molecular pharmacology.
[16] C. Cobelli,et al. Methods for assessment of the rate of onset and offset of insulin action during nonsteady state in humans. , 1993, The American journal of physiology.
[17] S. Post,et al. Mechanism of action of des-His1-[Glu9]glucagon amide, a peptide antagonist of the glucagon receptor system. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[18] M. Jensen,et al. Effects of glucagon on free fatty acid metabolism in humans. , 1991, The Journal of clinical endocrinology and metabolism.
[19] R. Rizza,et al. Contribution to Postprandial Hyperglycemia and Effect on Initial Splanchnic Glucose Clearance of Hepatic Glucose Cycling in Glucose-Intolerant or NIDDM Patients , 1991, Diabetes.
[20] A. Cherrington,et al. Effects of insulin on glucagon-stimulated glucose production in the conscious dog. , 1990, Metabolism: clinical and experimental.
[21] T. Jenssen,et al. Contribution of Abnormal Muscle and Liver Glucose Metabolism to Postprandial Hyperglycemia in NIDDM , 1990, Diabetes.
[22] T. Jenssen,et al. Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. , 1990, Diabetes.
[23] R. Rizza,et al. Effects of Basal Insulin Supplementation on Disposition of Mixed Meal in Obese Patients With NIDDM , 1989, Diabetes.
[24] Glucagon antagonists: contribution to binding and activity of the amino-terminal sequence 1-5, position 12, and the putative alpha-helical segment 19-27. , 1989, The Journal of biological chemistry.
[25] R. Hartung. Dose—Response Relationships , 1987 .
[26] R. Rizza,et al. Assessment of insulin action in insulin-dependent diabetes mellitus using [6(14)C]glucose, [3(3)H]glucose, and [2(3)H]glucose. Differences in the apparent pattern of insulin resistance depending on the isotope used. , 1986, The Journal of clinical investigation.
[27] M. Vranic,et al. Minimal Increases in Glucagon Levels Enhance Glucose Production in Man with Partial Hypoinsulinemia , 1983, Diabetes.
[28] P. Cryer,et al. Mechanisms of postprandial glucose counterregulation in man. Physiologic roles of glucagon and epinephrine vis-a-vis insulin in the prevention of hypoglycemia late after glucose ingestion. , 1983, The Journal of clinical investigation.
[29] R. DeFronzo,et al. Transient hepatic response to glucagon in man: role of insulin and hyperglycemia. , 1982, The American journal of physiology.
[30] G. Shulman,et al. Differential Time Course of Glucagon's Effect on Glycogenolysis and Gluconeogenesis in the Conscious Dog , 1981, Diabetes.
[31] R. Sherwin,et al. Evidence for an important role of changes in rather than absolute concentrations of glucagon in the regulation of glucose production in humans. , 1980, The Journal of clinical endocrinology and metabolism.
[32] J. Liljenquist,et al. Lack of a role for glucagon in the disposal of an oral glucose load in normal man. , 1979, The Journal of clinical endocrinology and metabolism.
[33] P. Raskin,et al. Effects of insulin on the response of immunoreactive glucagon to an intravenous glucose load in human diabetes. , 1979, Metabolism: Clinical and Experimental.
[34] R. Rizza,et al. Persistent effect of sustained hyperglucagonemia on glucose production in man. , 1979, The Journal of clinical endocrinology and metabolism.
[35] R. Sherwin,et al. Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects. , 1976, The New England journal of medicine.
[36] R. Steele,et al. Measurement of size and turnover rate of body glucose pool by the isotope dilution method. , 1956, The American journal of physiology.